Paydirt
KA
Insider

Kevin Ali

Chief Executive Officer

Kevin Ali (Chief Executive Officer) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in Organon & Co. (OGN). Across 1 priced purchase filing, the average 21-session return was +1.1% from execution and +10.9% from disclosure (delay-adjusted; derived). The largest single filing was $300K of OGN (34,000 sh × $8.81, as filed), executed May 5 2025.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
+1.1%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+10.9%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
1d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$300K
shares × price, as filed
Last traded
May 5 2025
Filed May 6 2025

Median ADV $37.2M across their filed names

Open performance
Volume by month
$300K$150K$0Oct 2024Apr 2025Oct 2025Apr 2026May 2025 · buys $300K
Buys $300K Sells $0

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 24 months

Most traded names
OGN Organon & Co. OGN · 1 buy · 0 sells 1 filing
Recent filings
OGNPURCHASE Organon & Co. View filing → $300K
34,000 sh × $8.81
Exec May 5 2025
Filed May 6 2025 · 5:30 PM ET